Endoscopic Eradication Therapy of Barrett’s Esophagus and Related Neoplasia
Overview
Learn from the authors of AGA’s latest clinical practice guideline. Barrett’s esophagus (BE) is the pre-cursor to esophageal adenocarcinoma (EAC). Endoscopic eradication therapy (EET) can be effective in eradicating BE and related neoplasia, but has greater risk of harms and resource use than surveillance endoscopy. This webinar provides clinicians with evidence-based practice recommendations for the use of EET in BE and related neoplasia. View the guideline here.
Learning objectives
Guideline authors share best practices and provide:
- A comprehensive outline of the indications for EET in the management of BE and related neoplasia
- Guidance regarding the considerations surrounding implementation of EET
Key dates
- Released date:
- Jun 11, 2024
- Expiration date:
- Jun 27, 2026
Pricing
Agenda
All times are Eastern.
Session Heading 1: Lorem Ipsum Dolor sit Amet
10:00 a.m. - 5:00 p.m.
Session Sub-title 1
Person, PhD
10:00 - 11:00 a.m.
Session Sub-title 2
Person, PhD
11:00 - 12:00 midday
Session Sub-title 3
Person, PhD
12:00 - 1:00 p.m.
Session Heading 2: Lorem Ipsum Dolor sit Amet
10:00 a.m. - 5:00 p.m.
Session Sub-title 1
Person, PhD
10:00 - 11:00 a.m.
Session Sub-title 2
Person, PhD
11:00 - 12:00 midday
Session Sub-title 3
Person, PhD
12:00 - 1:00 p.m.
Course contents
Video
31 mins
Evaluation
Course Faculty
Speaker
Swathi Eluri, MD MSCR
Senior Associate Consultant Director, Esophageal Diseases Group Division of Gastroenterology and Hepatology Mayo Clinic Florida
Joel H. Rubenstein, MD, MS, AGAF
Research Scientist, Veterans Affairs Center for Clinical Management Research LTC Charles S. Kettles Veterans Affairs Medical Center Director, Barrett’s Esophagus Program and Professor, Division of Gastroenterology, University of Michigan Medical School
Tarek Sawas, MD, MPH
Assistant Professor of Medicine Advanced Endoscopy Fellowship Program Director Division of Digestive and Liver Diseases University of Texas Southwestern, Dallas, TX
Sachin Wani, MD
Katy O and Paul M Rady Endowed Chair in Esophageal Cancer Research Professor of Medicine Executive Director, Katy O and Paul M Rady Esophageal and Gastric Center of Excellence Co-Director, GI Outcomes Research Group Division of Gastroenterology and Hepatology University of Colorado Anschutz Medical Campus